Entrada Therapeutics, Inc. (TRDA) Surpasses Q4 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of$ 0.66 per share. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 104.55%. A quarter ago, it was expected that this company would post a loss of$ 0.67 per share when it actually produced a loss of $0.35, delivering a surprise of 47.76%.Over the last four quarters ...